Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroconvulsive Therapy | 17 | 2024 | 502 | 3.670 |
Why?
|
Geriatric Psychiatry | 13 | 2021 | 71 | 3.410 |
Why?
|
Dementia | 23 | 2024 | 2649 | 3.090 |
Why?
|
Psychomotor Agitation | 15 | 2024 | 305 | 2.920 |
Why?
|
Bipolar Disorder | 35 | 2024 | 5078 | 2.850 |
Why?
|
Mood Disorders | 3 | 2024 | 1124 | 1.440 |
Why?
|
Antipsychotic Agents | 10 | 2022 | 3061 | 1.410 |
Why?
|
Alzheimer Disease | 19 | 2023 | 8547 | 1.410 |
Why?
|
Antimanic Agents | 4 | 2018 | 520 | 1.390 |
Why?
|
Depressive Disorder, Major | 21 | 2024 | 4744 | 1.340 |
Why?
|
Spirituality | 6 | 2024 | 428 | 1.330 |
Why?
|
Aging | 23 | 2024 | 8651 | 1.210 |
Why?
|
Antidepressive Agents | 9 | 2020 | 2890 | 1.010 |
Why?
|
Religion | 5 | 2024 | 376 | 0.940 |
Why?
|
Aggression | 8 | 2022 | 745 | 0.940 |
Why?
|
Mental Disorders | 12 | 2021 | 6796 | 0.940 |
Why?
|
Aspartic Acid | 2 | 2019 | 576 | 0.810 |
Why?
|
Ubiquinone | 2 | 2015 | 183 | 0.810 |
Why?
|
Coronavirus Infections | 6 | 2020 | 3085 | 0.770 |
Why?
|
Pneumonia, Viral | 6 | 2020 | 3205 | 0.760 |
Why?
|
Magnetic Resonance Spectroscopy | 9 | 2021 | 3765 | 0.760 |
Why?
|
Long-Term Care | 2 | 2020 | 632 | 0.720 |
Why?
|
Caregivers | 6 | 2023 | 2224 | 0.700 |
Why?
|
Energy Metabolism | 7 | 2021 | 2869 | 0.660 |
Why?
|
Lithium Compounds | 5 | 2022 | 225 | 0.640 |
Why?
|
Neuropsychological Tests | 9 | 2024 | 7021 | 0.630 |
Why?
|
Inpatients | 2 | 2021 | 2581 | 0.620 |
Why?
|
Aged | 76 | 2024 | 169152 | 0.620 |
Why?
|
Pandemics | 6 | 2020 | 8624 | 0.620 |
Why?
|
Psychiatric Department, Hospital | 1 | 2018 | 126 | 0.620 |
Why?
|
Depressive Disorder | 4 | 2021 | 3726 | 0.570 |
Why?
|
Organizational Innovation | 1 | 2020 | 536 | 0.570 |
Why?
|
Citalopram | 2 | 2020 | 402 | 0.570 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2021 | 6015 | 0.520 |
Why?
|
Adaptation, Psychological | 3 | 2024 | 2628 | 0.500 |
Why?
|
Phosphocreatine | 1 | 2016 | 261 | 0.500 |
Why?
|
Religion and Psychology | 3 | 2024 | 178 | 0.490 |
Why?
|
Movement | 2 | 2019 | 1474 | 0.490 |
Why?
|
Humans | 138 | 2024 | 760621 | 0.480 |
Why?
|
Valproic Acid | 3 | 2017 | 441 | 0.470 |
Why?
|
Pharmacogenetics | 5 | 2020 | 680 | 0.450 |
Why?
|
Cognition Disorders | 3 | 2020 | 3976 | 0.440 |
Why?
|
Health Services Needs and Demand | 2 | 2020 | 1399 | 0.430 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.430 |
Why?
|
Brain | 10 | 2024 | 26951 | 0.420 |
Why?
|
Memory | 2 | 2020 | 2179 | 0.420 |
Why?
|
Psychotic Disorders | 7 | 2021 | 3193 | 0.420 |
Why?
|
Geriatric Assessment | 5 | 2017 | 1405 | 0.410 |
Why?
|
Phosphates | 1 | 2016 | 772 | 0.400 |
Why?
|
Psychotropic Drugs | 6 | 2020 | 883 | 0.400 |
Why?
|
Assisted Living Facilities | 2 | 2014 | 26 | 0.390 |
Why?
|
Organophosphorus Compounds | 1 | 2013 | 202 | 0.390 |
Why?
|
Hospice Care | 1 | 2018 | 692 | 0.380 |
Why?
|
Suicide | 1 | 2022 | 1599 | 0.370 |
Why?
|
Affective Symptoms | 1 | 2013 | 416 | 0.360 |
Why?
|
Primary Health Care | 5 | 2023 | 4647 | 0.360 |
Why?
|
Mental Health | 7 | 2023 | 3213 | 0.360 |
Why?
|
Sertraline | 2 | 2021 | 208 | 0.350 |
Why?
|
Creatine Kinase | 1 | 2012 | 691 | 0.340 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1501 | 0.340 |
Why?
|
Affect | 4 | 2023 | 1480 | 0.340 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 1993 | 0.340 |
Why?
|
Lithium Carbonate | 2 | 2016 | 179 | 0.330 |
Why?
|
Curriculum | 3 | 2021 | 3718 | 0.330 |
Why?
|
Home Care Services | 1 | 2015 | 654 | 0.320 |
Why?
|
Cognition | 15 | 2023 | 6957 | 0.310 |
Why?
|
Drug Utilization | 1 | 2015 | 1195 | 0.310 |
Why?
|
Patient Care Team | 1 | 2019 | 2511 | 0.300 |
Why?
|
Male | 60 | 2024 | 359744 | 0.300 |
Why?
|
Health Services for the Aged | 2 | 2020 | 259 | 0.290 |
Why?
|
Inositol | 1 | 2008 | 215 | 0.290 |
Why?
|
Ketamine | 2 | 2023 | 516 | 0.290 |
Why?
|
Executive Function | 1 | 2016 | 1374 | 0.280 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8056 | 0.280 |
Why?
|
Female | 59 | 2024 | 391270 | 0.280 |
Why?
|
Depression | 5 | 2023 | 8044 | 0.270 |
Why?
|
Health Care Costs | 1 | 2019 | 3258 | 0.270 |
Why?
|
Phospholipids | 1 | 2010 | 789 | 0.260 |
Why?
|
Aged, 80 and over | 19 | 2019 | 58995 | 0.260 |
Why?
|
Middle Aged | 44 | 2024 | 220352 | 0.260 |
Why?
|
Referral and Consultation | 1 | 2018 | 3598 | 0.250 |
Why?
|
Brain Diseases | 1 | 2014 | 1540 | 0.250 |
Why?
|
Facial Expression | 2 | 2019 | 508 | 0.250 |
Why?
|
Lithium | 3 | 2023 | 596 | 0.240 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3388 | 0.230 |
Why?
|
Treatment Failure | 2 | 2020 | 2648 | 0.220 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5761 | 0.220 |
Why?
|
Single-Blind Method | 2 | 2024 | 1578 | 0.220 |
Why?
|
Treatment Outcome | 20 | 2024 | 65017 | 0.220 |
Why?
|
Fellowships and Scholarships | 3 | 2021 | 1116 | 0.210 |
Why?
|
Education, Nursing | 1 | 2023 | 79 | 0.200 |
Why?
|
Mental Recall | 2 | 2020 | 1206 | 0.200 |
Why?
|
Psychotherapy | 3 | 2021 | 1640 | 0.200 |
Why?
|
Financing, Organized | 1 | 2023 | 204 | 0.200 |
Why?
|
Health Services | 2 | 2023 | 753 | 0.190 |
Why?
|
Mental Health Services | 4 | 2021 | 1717 | 0.190 |
Why?
|
Patient Preference | 2 | 2020 | 922 | 0.180 |
Why?
|
Radio Frequency Identification Device | 1 | 2020 | 24 | 0.170 |
Why?
|
Phosphorus Isotopes | 2 | 2010 | 124 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36290 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2023 | 10344 | 0.170 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2020 | 115 | 0.170 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2020 | 107 | 0.170 |
Why?
|
Hospitalization | 2 | 2018 | 10790 | 0.160 |
Why?
|
Remote Sensing Technology | 1 | 2020 | 92 | 0.160 |
Why?
|
Students, Medical | 3 | 2021 | 1927 | 0.160 |
Why?
|
Registries | 1 | 2015 | 8469 | 0.160 |
Why?
|
Cannabinoids | 1 | 2021 | 173 | 0.160 |
Why?
|
Civil Defense | 1 | 2020 | 115 | 0.150 |
Why?
|
Personnel Selection | 1 | 2020 | 193 | 0.150 |
Why?
|
Disease Progression | 2 | 2021 | 13502 | 0.150 |
Why?
|
Psychological Techniques | 1 | 2017 | 47 | 0.150 |
Why?
|
Accreditation | 2 | 2021 | 477 | 0.150 |
Why?
|
Expert Testimony | 1 | 2020 | 361 | 0.150 |
Why?
|
Drug Substitution | 1 | 2020 | 296 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2020 | 22053 | 0.140 |
Why?
|
Narration | 1 | 2019 | 219 | 0.140 |
Why?
|
Emotions | 2 | 2019 | 2734 | 0.140 |
Why?
|
Creatine | 1 | 2019 | 426 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2017 | 6498 | 0.140 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 25942 | 0.130 |
Why?
|
Glutamine | 1 | 2019 | 576 | 0.130 |
Why?
|
Comorbidity | 4 | 2024 | 10551 | 0.130 |
Why?
|
Age Factors | 7 | 2019 | 18416 | 0.130 |
Why?
|
Spectrum Analysis | 1 | 2017 | 453 | 0.130 |
Why?
|
Placebos | 2 | 1999 | 1668 | 0.120 |
Why?
|
Memory Disorders | 2 | 2020 | 1197 | 0.120 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5325 | 0.120 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2502 | 0.120 |
Why?
|
Spiritual Therapies | 1 | 2015 | 60 | 0.120 |
Why?
|
Disaster Medicine | 1 | 2015 | 70 | 0.120 |
Why?
|
Psychiatry | 2 | 2014 | 1689 | 0.120 |
Why?
|
Suicidal Ideation | 2 | 2022 | 1425 | 0.120 |
Why?
|
Activities of Daily Living | 5 | 2023 | 2417 | 0.110 |
Why?
|
Clinical Clerkship | 1 | 2020 | 563 | 0.110 |
Why?
|
Adult | 22 | 2024 | 219994 | 0.110 |
Why?
|
Tai Ji | 1 | 2017 | 287 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1392 | 0.110 |
Why?
|
Education, Medical, Graduate | 3 | 2021 | 2363 | 0.110 |
Why?
|
Glutamic Acid | 1 | 2019 | 1167 | 0.110 |
Why?
|
Glycerylphosphorylcholine | 1 | 2013 | 25 | 0.110 |
Why?
|
Internship and Residency | 3 | 2021 | 5870 | 0.110 |
Why?
|
Delirium | 2 | 2022 | 1663 | 0.110 |
Why?
|
Telemedicine | 2 | 2020 | 3018 | 0.110 |
Why?
|
Research Design | 2 | 2019 | 6180 | 0.100 |
Why?
|
Phosphatidylethanolamines | 1 | 2013 | 129 | 0.100 |
Why?
|
Alcoholism | 1 | 2023 | 1961 | 0.100 |
Why?
|
Ethanolamines | 1 | 2013 | 154 | 0.100 |
Why?
|
Phosphorylcholine | 1 | 2013 | 153 | 0.100 |
Why?
|
Behavioral Symptoms | 2 | 2020 | 185 | 0.100 |
Why?
|
Demography | 3 | 2023 | 1650 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1784 | 0.100 |
Why?
|
Mitochondria | 3 | 2021 | 3600 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2021 | 1084 | 0.100 |
Why?
|
Education, Medical, Undergraduate | 1 | 2021 | 1066 | 0.100 |
Why?
|
Preventive Medicine | 1 | 2013 | 250 | 0.100 |
Why?
|
Policy Making | 1 | 2015 | 538 | 0.100 |
Why?
|
Retrospective Studies | 10 | 2023 | 80372 | 0.100 |
Why?
|
Sex Characteristics | 2 | 2023 | 2629 | 0.090 |
Why?
|
Psychometrics | 2 | 2019 | 3051 | 0.090 |
Why?
|
Anxiety Disorders | 2 | 2019 | 2714 | 0.090 |
Why?
|
Anxiety | 3 | 2020 | 4538 | 0.090 |
Why?
|
Young Adult | 8 | 2021 | 58741 | 0.090 |
Why?
|
Geriatrics | 1 | 2015 | 387 | 0.090 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 726 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3113 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2023 | 7475 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2754 | 0.090 |
Why?
|
Drug Resistance | 1 | 2016 | 1617 | 0.090 |
Why?
|
Data Collection | 3 | 2023 | 3315 | 0.090 |
Why?
|
Psychotherapy, Group | 1 | 1993 | 410 | 0.090 |
Why?
|
Sex Factors | 7 | 2024 | 10547 | 0.090 |
Why?
|
Independent Living | 1 | 2014 | 570 | 0.080 |
Why?
|
Chronic Disease | 3 | 2019 | 9287 | 0.080 |
Why?
|
Double-Blind Method | 6 | 2021 | 12427 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15840 | 0.080 |
Why?
|
Specialization | 1 | 2014 | 778 | 0.080 |
Why?
|
Linear Models | 2 | 2010 | 5877 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3164 | 0.080 |
Why?
|
Social Participation | 2 | 2021 | 183 | 0.080 |
Why?
|
Frontal Lobe | 2 | 2021 | 1420 | 0.080 |
Why?
|
Medicine | 1 | 2017 | 943 | 0.080 |
Why?
|
Schizophrenia | 4 | 2018 | 6915 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1469 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4283 | 0.070 |
Why?
|
Social Adjustment | 1 | 2010 | 632 | 0.070 |
Why?
|
Seizures | 1 | 2020 | 2917 | 0.070 |
Why?
|
Self Report | 1 | 2019 | 3711 | 0.070 |
Why?
|
United States | 9 | 2023 | 72461 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3905 | 0.070 |
Why?
|
Adolescent | 7 | 2021 | 87810 | 0.070 |
Why?
|
Residential Facilities | 1 | 2007 | 42 | 0.070 |
Why?
|
Freedom | 1 | 2007 | 70 | 0.070 |
Why?
|
Radiotherapy | 1 | 1993 | 1504 | 0.070 |
Why?
|
Age of Onset | 2 | 2015 | 3301 | 0.070 |
Why?
|
Amyloid beta-Peptides | 1 | 2020 | 3832 | 0.070 |
Why?
|
Anorexia | 3 | 2013 | 154 | 0.070 |
Why?
|
Mentors | 2 | 2023 | 661 | 0.070 |
Why?
|
Massachusetts | 2 | 2023 | 8803 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2852 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8552 | 0.070 |
Why?
|
Central Nervous System Stimulants | 1 | 2015 | 1174 | 0.070 |
Why?
|
Brain Mapping | 2 | 2021 | 6568 | 0.070 |
Why?
|
Life Style | 1 | 2017 | 3896 | 0.060 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 340 | 0.060 |
Why?
|
Forecasting | 1 | 2014 | 2932 | 0.060 |
Why?
|
Gait Disorders, Neurologic | 1 | 2007 | 238 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2009 | 959 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6238 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2010 | 936 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6360 | 0.060 |
Why?
|
Self Efficacy | 2 | 2010 | 630 | 0.060 |
Why?
|
Stress, Psychological | 2 | 1993 | 4446 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3426 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4925 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4013 | 0.060 |
Why?
|
Schizophrenic Psychology | 1 | 2010 | 1646 | 0.050 |
Why?
|
Prevalence | 4 | 2024 | 15687 | 0.050 |
Why?
|
Protons | 1 | 2008 | 1114 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39261 | 0.050 |
Why?
|
Community Mental Health Services | 1 | 2005 | 392 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4555 | 0.050 |
Why?
|
Databases, Factual | 3 | 2024 | 8035 | 0.050 |
Why?
|
Endocrine System Diseases | 1 | 2024 | 250 | 0.050 |
Why?
|
Control Groups | 1 | 2022 | 104 | 0.050 |
Why?
|
Terminal Care | 1 | 2014 | 1758 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5787 | 0.050 |
Why?
|
Quality of Life | 3 | 2021 | 13308 | 0.050 |
Why?
|
Proxy | 1 | 2022 | 148 | 0.050 |
Why?
|
Sleep | 1 | 2017 | 4751 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 319 | 0.050 |
Why?
|
Nursing Homes | 2 | 2020 | 1082 | 0.050 |
Why?
|
Professional Competence | 1 | 2004 | 431 | 0.050 |
Why?
|
China | 2 | 2017 | 2339 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2005 | 908 | 0.040 |
Why?
|
Length of Stay | 1 | 2014 | 6479 | 0.040 |
Why?
|
Smoking | 1 | 2017 | 9073 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 599 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 54303 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2019 | 64 | 0.040 |
Why?
|
Ecosystem | 1 | 2023 | 485 | 0.040 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 595 | 0.040 |
Why?
|
Anesthetics | 1 | 2023 | 522 | 0.040 |
Why?
|
Risk Factors | 2 | 2016 | 74359 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 176 | 0.040 |
Why?
|
Propofol | 1 | 2023 | 608 | 0.040 |
Why?
|
Happiness | 1 | 2019 | 170 | 0.040 |
Why?
|
Problem-Based Learning | 1 | 2021 | 352 | 0.040 |
Why?
|
Social Isolation | 1 | 2020 | 362 | 0.040 |
Why?
|
Macau | 1 | 2016 | 1 | 0.040 |
Why?
|
Videotape Recording | 1 | 1998 | 337 | 0.040 |
Why?
|
Employment | 1 | 2023 | 1112 | 0.040 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2019 | 324 | 0.030 |
Why?
|
Nausea | 2 | 1993 | 678 | 0.030 |
Why?
|
Pilot Projects | 2 | 2007 | 8555 | 0.030 |
Why?
|
Anger | 1 | 2019 | 401 | 0.030 |
Why?
|
Cohort Studies | 4 | 2022 | 41335 | 0.030 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2020 | 498 | 0.030 |
Why?
|
Vomiting | 2 | 1993 | 650 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2019 | 412 | 0.030 |
Why?
|
Decision Support Systems, Clinical | 1 | 2005 | 1164 | 0.030 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1190 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 852 | 0.030 |
Why?
|
Quality Assurance, Health Care | 1 | 2005 | 2176 | 0.030 |
Why?
|
Genomics | 2 | 2021 | 5794 | 0.030 |
Why?
|
Quality Improvement | 2 | 2021 | 3836 | 0.030 |
Why?
|
Standard of Care | 1 | 2019 | 552 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2022 | 978 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2020 | 696 | 0.030 |
Why?
|
Homes for the Aged | 1 | 2016 | 272 | 0.030 |
Why?
|
Attitude to Health | 3 | 1998 | 2029 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2022 | 1378 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 844 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2315 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 828 | 0.030 |
Why?
|
Reaction Time | 1 | 2020 | 2075 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2024 | 2093 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 1066 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2392 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2394 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1433 | 0.030 |
Why?
|
Clozapine | 1 | 2016 | 506 | 0.030 |
Why?
|
Fatigue | 2 | 1993 | 1544 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2020 | 768 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20080 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2018 | 965 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2020 | 1135 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1139 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2222 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2013 | 238 | 0.020 |
Why?
|
Weight Gain | 1 | 2021 | 2347 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2023 | 1830 | 0.020 |
Why?
|
Neoplasms | 2 | 1993 | 22072 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2000 | 1673 | 0.020 |
Why?
|
Certification | 1 | 2014 | 421 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3106 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1469 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 13981 | 0.020 |
Why?
|
Accidental Falls | 1 | 2018 | 1056 | 0.020 |
Why?
|
Fear | 1 | 2019 | 1462 | 0.020 |
Why?
|
Research | 1 | 1999 | 1974 | 0.020 |
Why?
|
Visual Perception | 1 | 1998 | 1374 | 0.020 |
Why?
|
Universities | 1 | 2015 | 992 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 2963 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2138 | 0.020 |
Why?
|
Clinical Competence | 2 | 2020 | 4783 | 0.020 |
Why?
|
Decision Making | 1 | 2022 | 3925 | 0.020 |
Why?
|
Case Management | 1 | 2010 | 272 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4899 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3078 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3448 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4090 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14660 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9631 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5423 | 0.020 |
Why?
|
Communication | 1 | 2020 | 3849 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14495 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2493 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2020 | 4360 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12960 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6786 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15289 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10827 | 0.010 |
Why?
|
Social Behavior | 1 | 2010 | 1131 | 0.010 |
Why?
|
Time Factors | 2 | 2017 | 40165 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2010 | 1826 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5397 | 0.010 |
Why?
|
New England | 1 | 2005 | 1050 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7806 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16546 | 0.010 |
Why?
|
Child | 2 | 2019 | 79806 | 0.010 |
Why?
|
Cost of Illness | 1 | 2010 | 1940 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8950 | 0.010 |
Why?
|
Awareness | 1 | 1985 | 646 | 0.010 |
Why?
|
New Hampshire | 1 | 2000 | 173 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29658 | 0.010 |
Why?
|
Utilization Review | 1 | 2000 | 383 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15757 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8594 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24123 | 0.010 |
Why?
|
Patient Admission | 1 | 2000 | 1386 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2005 | 3865 | 0.010 |
Why?
|
Animals | 1 | 2023 | 167963 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2000 | 2781 | 0.000 |
Why?
|
Health Status | 1 | 1998 | 4081 | 0.000 |
Why?
|